INFLUENZA A
Clinical trials for INFLUENZA A explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA A trials appear
Sign up with your email to follow new studies for INFLUENZA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New flu pill shows promise in early human safety trial
Disease control CompletedThis early-stage study tested a new oral drug called CC-42344 in 80 healthy adults to see if it is safe and how the body handles it. The drug aims to stop the influenza A virus from multiplying. The study was completed, and results will help decide if further testing is needed.
Matched conditions: INFLUENZA A
Phase: PHASE1 • Sponsor: Cocrystal Pharma, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New at-home test aims to detect three respiratory viruses at once
Diagnosis CompletedThis study checked how well a new rapid test (iHealth Flu A&B/COVID-19/RSV) works for people with respiratory symptoms. Over 1,100 participants gave nasal samples, which were compared to standard lab tests. The goal was to see if the test accurately detects influenza, COVID-19, a…
Matched conditions: INFLUENZA A
Sponsor: iHealth Labs inc • Aim: Diagnosis
Last updated May 20, 2026 11:53 UTC
-
New rapid test for COVID and flu put to the test
Diagnosis CompletedThis study checked how well a new rapid test (iHealth COVID-19/Flu A&B) can detect COVID-19 and flu A&B in people with respiratory symptoms. 588 people with two or more symptoms (like fever, cough, or sore throat) gave nose swabs for the test and a standard lab test. The goal was…
Matched conditions: INFLUENZA A
Sponsor: iHealth Labs inc • Aim: Diagnosis
Last updated May 11, 2026 20:53 UTC
-
New flu drug shows promise in kids – phase 2 trial complete
Symptom relief CompletedThis study tested a new flu medicine called ZSP1273 in 72 children aged 2 to 17 who had influenza A. The goal was to check how safe the drug is, how it moves through the body, and how well it works. Researchers measured drug levels in the blood, tracked side effects, and recorded…
Matched conditions: INFLUENZA A
Phase: PHASE2 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 09:55 UTC
-
Flu's hidden threat: deadly fungus strikes ICU patients
Knowledge-focused CompletedThis study looked at over 500 adults in intensive care with severe flu to understand why some develop a serious fungal lung infection called aspergillosis. Researchers reviewed medical records from 20 hospitals in China to find risk factors and track survival. The goal is to help…
Matched conditions: INFLUENZA A
Sponsor: Jianfeng Xie • Aim: Knowledge-focused
Last updated May 26, 2026 09:52 UTC
-
Flu vaccine showdown: 2023 vs 2024 in a Late-Season test
Knowledge-focused CompletedThis study looked at how well the 2023 and 2024 flu vaccines work by giving the 2023 vaccine to 23 adults late in the season (May-June 2024). Researchers compared their immune responses to those who got the 2023 vaccine in fall 2023 and those who will get the 2024 vaccine in fall…
Matched conditions: INFLUENZA A
Phase: PHASE4 • Sponsor: La Jolla Institute for Immunology • Aim: Knowledge-focused
Last updated May 26, 2026 09:49 UTC